|
FY2022
12 months to Mar 31, 2022
|
FY2021
12 months to Mar 31, 2021
|
FY2020
12 months to Mar 31, 2020
|
FY2019
12 months to Mar 31, 2019
|
FY2018
12 months to Mar 31, 2018
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Product Sales | |||||
| Other Revenues | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| Research and development, net of government grants | |||||
| General and administrative expense: | |||||
| Compensation expense in respect of share options and management equity incentives | |||||
| Other general and administrative expenses | |||||
| Total general and administrative expense | |||||
| Total operating expense | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| Interest expense, net | |||||
| Other, net | |||||
| Other income (expense), net | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Change in fair value of effective portion of foreign currency cash flow hedges | |||||
| Unrealized loss on short-term investments | |||||
| Foreign currency gain (loss) | |||||
| Provision for pension benefit obligation | |||||
| Other comprehensive loss, net | |||||
| Comprehensive loss | |||||
| Net loss available to ordinary shareholders - basic and diluted | |||||
| Loss per share - basic and diluted | |||||
| Weighted-average shares outstanding - basic and diluted |
Loading...